Target Name: OPN1LW
NCBI ID: G5956
Review Report on OPN1LW Target / Biomarker Content of Review Report on OPN1LW Target / Biomarker
OPN1LW
Other Name(s): COD5 | OPSR_HUMAN | red cone opsin | opsin 1, long wave sensitive | CBP | Red-sensitive opsin | RCP | red cone photoreceptor pigment | Long-wave-sensitive opsin 1 | ROP | opsin 1 (cone pigments), long-wave-sensitive | Red cone pigment | Red cone photoreceptor pigment | red-sensitive opsin | CBBM | Opsin 1, long wave sensitive | cone dystrophy 5 (X-linked)

OPN1LW: Potential Drug Target and Biomarker for Neurological Disorders

OPN1LW, also known as COD5, is a protein that is expressed in the nuclei of the brain and is involved in the development and progression of several neurological disorders, including neurodegenerative diseases. OPN1LW has also been identified as a potential drug target and biomarker for several neurological disorders, making it an important topic of research in the field of neuroscience.

The OPN1LW protein is a member of the TATA-repeat gene family, which is a conserved group of transcription factors that are involved in the regulation of gene expression. The TATA-repeat gene family includes several transcription factors, including OPN1LW, which is expressed in various tissues throughout the body, including the brain.

OPN1LW is involved in the regulation of cell proliferation and has been shown to play a role in the development and progression of several neurological disorders. For example, studies have shown that OPN1LW is expressed in the nuclei of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease , and Huntington's disease. Additionally, overexpression of OPN1LW has been shown to cause neurotoxicity in several animal models of neurodegenerative diseases.

OPN1LW is also a potential drug target for several neurological disorders. The neurodegenerative diseases that OPN1LW is involved in are some of the most common and devastating disorders that affect human beings. For example, Alzheimer's disease is the most common form of dementia, affecting over 50 million people worldwide, while Parkinson's disease and Huntington's disease are also common disorders that can cause significant disability and quality of life.

The potential drug targets for OPN1LW are based on its involvement in the development and progression of neurodegenerative diseases. OPN1LW has been shown to play a role in the regulation of neurogenesis, which is the process by which new neurons are generated in the brain. Additionally, OPN1LW has been shown to regulate the apoptosis, which is the process by which cells die, which is a common hallmark of neurodegenerative diseases.

OPN1LW has also been shown to play a role in the regulation of cellular signaling pathways, including the TGF-β pathway. TGF-β is a signaling pathway that is involved in the regulation of cell growth, differentiation, and survival, and is a potential drug target for OPN1LW.

In conclusion, OPN1LW is a protein that is involved in the development and progression of several neurological disorders, including neurodegenerative diseases. Its potential as a drug target and biomarker makes it an important topic of research in the field of neuroscience. Further studies are needed to fully understand the role of OPN1LW in the regulation of neurogenesis and cellular signaling pathways, as well as its potential as a drug target for several neurological disorders.

Protein Name: Opsin 1, Long Wave Sensitive

Functions: Visual pigments are the light-absorbing molecules that mediate vision. They consist of an apoprotein, opsin, covalently linked to cis-retinal

The "OPN1LW Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OPN1LW comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OPN1MW | OPN1MW3 | OPN1SW | OPN3 | OPN4 | OPN5 | OPRD1 | OPRK1 | OPRL1 | OPRM1 | OPRPN | OPTC | OPTN | OR10A2 | OR10A3 | OR10A4 | OR10A5 | OR10A6 | OR10A7 | OR10AA1P | OR10AB1P | OR10AC1 | OR10AD1 | OR10AF1P | OR10AG1 | OR10AK1P | OR10C1 | OR10D1P | OR10D3 | OR10D4P | OR10G2 | OR10G3 | OR10G4 | OR10G7 | OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2